Lee Ainslie Pacific Biosciences Of California, Inc. Transaction History

Maverick Capital LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$3.99 - $7.82 $48.6 Million - $95.2 Million	-12,173,094 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.05 - $3.23 $1.95 Million - $3.07 Million	950,000 Added 8.46%	12,173,094 $25 Million
Q4 2017 Feb 13, 2018	BUY	$2.59 - $5.44 $1.6 Million - $3.37 Million	619,150 Added 5.84%	11,223,094 $29.6 Million
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $33.9 Million - $59.1 Million	10,603,944	10,603,944 $55.7 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.